Novel insights of vulvodynia pathophysiology from reliable and comprehensive pelvic floor muscle surface electromyography characterization: can it help predict response to botulinum toxin treatment?

[EN] Background Findings on vulvodynia-associated alterations in the pelvic floor muscles' (PFMs') myoelectrical activity are contradictory, and no study has yet assessed whether they influence treatment outcomes.Aim To characterize vulvodynia-associated alterations in PFM activity...

Descripción completa

Detalles Bibliográficos
Autores: Albaladejo-Belmonte, Mónica, Villa-Muñoz, Paula, Nohales-Alfonso, F.J., Novillo-Del Álamo, Blanca, Alberola Rubio, José, Garcia-Casado, Javier|||0000-0003-1410-2721
Tipo de recurso: artículo
Fecha de publicación:2025
País:España
Institución:Universitat Politècnica de València (UPV)
Repositorio:RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Idioma:inglés
OAI Identifier:oai:riunet.upv.es:10251/226593
Acceso en línea:https://riunet.upv.es/handle/10251/226593
Access Level:acceso abierto
Palabra clave:Botulinum toxin
Chronic pelvic pain
Pelvic floor muscles
Surface electromyography
Vestibulodynia
Vulvodynia
id ES_d4d766bf106406bc01bedff4fcb8d00c
oai_identifier_str oai:riunet.upv.es:10251/226593
network_acronym_str ES
network_name_str España
repository_id_str
dc.title.none.fl_str_mv Novel insights of vulvodynia pathophysiology from reliable and comprehensive pelvic floor muscle surface electromyography characterization: can it help predict response to botulinum toxin treatment?
title Novel insights of vulvodynia pathophysiology from reliable and comprehensive pelvic floor muscle surface electromyography characterization: can it help predict response to botulinum toxin treatment?
spellingShingle Novel insights of vulvodynia pathophysiology from reliable and comprehensive pelvic floor muscle surface electromyography characterization: can it help predict response to botulinum toxin treatment?
Albaladejo-Belmonte, Mónica
Botulinum toxin
Chronic pelvic pain
Pelvic floor muscles
Surface electromyography
Vestibulodynia
Vulvodynia
title_short Novel insights of vulvodynia pathophysiology from reliable and comprehensive pelvic floor muscle surface electromyography characterization: can it help predict response to botulinum toxin treatment?
title_full Novel insights of vulvodynia pathophysiology from reliable and comprehensive pelvic floor muscle surface electromyography characterization: can it help predict response to botulinum toxin treatment?
title_fullStr Novel insights of vulvodynia pathophysiology from reliable and comprehensive pelvic floor muscle surface electromyography characterization: can it help predict response to botulinum toxin treatment?
title_full_unstemmed Novel insights of vulvodynia pathophysiology from reliable and comprehensive pelvic floor muscle surface electromyography characterization: can it help predict response to botulinum toxin treatment?
title_sort Novel insights of vulvodynia pathophysiology from reliable and comprehensive pelvic floor muscle surface electromyography characterization: can it help predict response to botulinum toxin treatment?
dc.creator.none.fl_str_mv Albaladejo-Belmonte, Mónica
Villa-Muñoz, Paula
Nohales-Alfonso, F.J.
Novillo-Del Álamo, Blanca
Alberola Rubio, José
Garcia-Casado, Javier|||0000-0003-1410-2721
author Albaladejo-Belmonte, Mónica
author_facet Albaladejo-Belmonte, Mónica
Villa-Muñoz, Paula
Nohales-Alfonso, F.J.
Novillo-Del Álamo, Blanca
Alberola Rubio, José
Garcia-Casado, Javier|||0000-0003-1410-2721
author_role author
author2 Villa-Muñoz, Paula
Nohales-Alfonso, F.J.
Novillo-Del Álamo, Blanca
Alberola Rubio, José
Garcia-Casado, Javier|||0000-0003-1410-2721
author2_role author
author
author
author
author
dc.contributor.none.fl_str_mv Departamento de Ingeniería Electrónica
Escuela Técnica Superior de Ingeniería Industrial
Centro de Investigación e Innovación en Bioingeniería
Generalitat Valenciana
Universitat Politècnica de València
Repositorio Institucional de la Universitat Politècnica de València Riunet
dc.subject.none.fl_str_mv Botulinum toxin
Chronic pelvic pain
Pelvic floor muscles
Surface electromyography
Vestibulodynia
Vulvodynia
topic Botulinum toxin
Chronic pelvic pain
Pelvic floor muscles
Surface electromyography
Vestibulodynia
Vulvodynia
description [EN] Background Findings on vulvodynia-associated alterations in the pelvic floor muscles' (PFMs') myoelectrical activity are contradictory, and no study has yet assessed whether they influence treatment outcomes.Aim To characterize vulvodynia-associated alterations in PFM activity and assess its potential to predict the response to botulinum toxin type A (BoNT/A) treatment.Methods This prospective, non-masked, and non-randomized study recruited 35 vulvodynia patients who underwent BoNT/A injections and 35 healthy women. Their left and right PFM activity was monitored by surface electromyography (sEMG) with 2 recording modalities (intravaginal probe and external electrodes) during PFM contractions and rest and compared across groups at baseline. Clinical information was also collected from their medical history, pelvic physical examination, and self-informed clinical questionnaires. Both sEMG and clinical features were used to predict the patient's response to treatment using multiple binary logistic regression models.Outcomes sEMG signals' root mean square (RMS), median frequency (MDF), sample entropy (SampEn), intramuscular and intermuscular magnitude-squared coherence (mscoh) and imaginary part of their coherency (iCOH), and clinical outcomes (sociodemographic, obstetric, gynecological, urological, and other general clinical characteristics; painful comorbidities; pelvic and vulvar pain sensitivity; Patient's Global Impression of Improvement).Results Vulvodynia patients exhibited significantly lower intensity during contractions (mscoh) during contractions (P = .004) and rest (P = .006) in the myoelectrical activity of their left superficial PFM (sEMG from external electrodes) and altered intermuscular coupling during contractions (>mscoh, P = .004) in their deep PFM (sEMG from intravaginal probe) than healthy women. Furthermore, intramuscular coupling at rest was significantly associated with response to treatment (P < .01) and predicted it accurately when combined with clinical information (AUC = 0.95).Clinical Implications PFM sEMG can provide valuable insights into vulvodynia pathophysiology and help optimize treatment selection, potentially reducing the economic and psychological impact of ineffective treatment.Strengths and Limitations This study provides a reliable and comprehensive description of PFM myoelectrical activity alterations in vulvodynia conditions, demonstrating for the first time that sEMG information can improve the prediction of treatment response. It is limited by a small sample size of intravaginal probe recordings due to pain elicited by probes during their insertion and signal quality.Conclusion Vulvodynia is associated with decreased activity intensity in the superficial PFM and altered electrical coupling, as shown by sEMG, which can enhance the precision of BoNT/A treatment response prediction and thus reduce the economic and psychological burden of ineffective treatment.
publishDate 2025
dc.date.none.fl_str_mv 2025
2025-09-01
dc.type.none.fl_str_mv journal article
http://purl.org/coar/resource_type/c_6501
VoR
http://purl.org/coar/version/c_970fb48d4fbd8a85
dc.type.openaire.fl_str_mv info:eu-repo/semantics/article
format article
dc.identifier.none.fl_str_mv https://riunet.upv.es/handle/10251/226593
url https://riunet.upv.es/handle/10251/226593
dc.language.none.fl_str_mv Inglés
eng
language_invalid_str_mv Inglés
language eng
dc.relation.none.fl_str_mv Generalitat Valenciana https://doi.org/10.13039/501100003359 ACIF%2F2021%2F012
Generalitat Valenciana https://doi.org/10.13039/501100003359 AICO%2F2021%2F126
dc.rights.none.fl_str_mv open access
http://purl.org/coar/access_right/c_abf2
Reconocimiento - No comercial (by-nc)
http://creativecommons.org/licenses/by-nc/4.0/
dc.rights.openaire.fl_str_mv info:eu-repo/semantics/openAccess
rights_invalid_str_mv open access
http://purl.org/coar/access_right/c_abf2
Reconocimiento - No comercial (by-nc)
http://creativecommons.org/licenses/by-nc/4.0/
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Oxford University Press
publisher.none.fl_str_mv Oxford University Press
dc.source.none.fl_str_mv reponame:RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
instname:Universitat Politècnica de València (UPV)
instname_str Universitat Politècnica de València (UPV)
reponame_str RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
collection RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1869420581931188224
spelling Novel insights of vulvodynia pathophysiology from reliable and comprehensive pelvic floor muscle surface electromyography characterization: can it help predict response to botulinum toxin treatment?Albaladejo-Belmonte, MónicaVilla-Muñoz, PaulaNohales-Alfonso, F.J.Novillo-Del Álamo, BlancaAlberola Rubio, JoséGarcia-Casado, Javier|||0000-0003-1410-2721Botulinum toxinChronic pelvic painPelvic floor musclesSurface electromyographyVestibulodyniaVulvodynia[EN] Background Findings on vulvodynia-associated alterations in the pelvic floor muscles' (PFMs') myoelectrical activity are contradictory, and no study has yet assessed whether they influence treatment outcomes.Aim To characterize vulvodynia-associated alterations in PFM activity and assess its potential to predict the response to botulinum toxin type A (BoNT/A) treatment.Methods This prospective, non-masked, and non-randomized study recruited 35 vulvodynia patients who underwent BoNT/A injections and 35 healthy women. Their left and right PFM activity was monitored by surface electromyography (sEMG) with 2 recording modalities (intravaginal probe and external electrodes) during PFM contractions and rest and compared across groups at baseline. Clinical information was also collected from their medical history, pelvic physical examination, and self-informed clinical questionnaires. Both sEMG and clinical features were used to predict the patient's response to treatment using multiple binary logistic regression models.Outcomes sEMG signals' root mean square (RMS), median frequency (MDF), sample entropy (SampEn), intramuscular and intermuscular magnitude-squared coherence (mscoh) and imaginary part of their coherency (iCOH), and clinical outcomes (sociodemographic, obstetric, gynecological, urological, and other general clinical characteristics; painful comorbidities; pelvic and vulvar pain sensitivity; Patient's Global Impression of Improvement).Results Vulvodynia patients exhibited significantly lower intensity during contractions (mscoh) during contractions (P = .004) and rest (P = .006) in the myoelectrical activity of their left superficial PFM (sEMG from external electrodes) and altered intermuscular coupling during contractions (>mscoh, P = .004) in their deep PFM (sEMG from intravaginal probe) than healthy women. Furthermore, intramuscular coupling at rest was significantly associated with response to treatment (P < .01) and predicted it accurately when combined with clinical information (AUC = 0.95).Clinical Implications PFM sEMG can provide valuable insights into vulvodynia pathophysiology and help optimize treatment selection, potentially reducing the economic and psychological impact of ineffective treatment.Strengths and Limitations This study provides a reliable and comprehensive description of PFM myoelectrical activity alterations in vulvodynia conditions, demonstrating for the first time that sEMG information can improve the prediction of treatment response. It is limited by a small sample size of intravaginal probe recordings due to pain elicited by probes during their insertion and signal quality.Conclusion Vulvodynia is associated with decreased activity intensity in the superficial PFM and altered electrical coupling, as shown by sEMG, which can enhance the precision of BoNT/A treatment response prediction and thus reduce the economic and psychological burden of ineffective treatment.This work was supported by Generalitat Valenciana in Programa para la promocion de I + D + i ACIF/2021/012, AICO/2021/126; and by unrestricted funding from Merz Pharma GmbH & Co. Funding for open access charge: CRUE-Universitat Politecnica de Valencia. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.Oxford University PressDepartamento de Ingeniería ElectrónicaEscuela Técnica Superior de Ingeniería IndustrialCentro de Investigación e Innovación en BioingenieríaGeneralitat ValencianaUniversitat Politècnica de ValènciaRepositorio Institucional de la Universitat Politècnica de València Riunet20252025-09-01journal articlehttp://purl.org/coar/resource_type/c_6501VoRhttp://purl.org/coar/version/c_970fb48d4fbd8a85info:eu-repo/semantics/articleapplication/pdfhttps://riunet.upv.es/handle/10251/226593reponame:RiuNet. Repositorio Institucional de la Universitat Politécnica de Valénciainstname:Universitat Politècnica de València (UPV)InglésengGeneralitat Valenciana https://doi.org/10.13039/501100003359 ACIF%2F2021%2F012Generalitat Valenciana https://doi.org/10.13039/501100003359 AICO%2F2021%2F126open accesshttp://purl.org/coar/access_right/c_abf2Reconocimiento - No comercial (by-nc) http://creativecommons.org/licenses/by-nc/4.0/info:eu-repo/semantics/openAccessoai:riunet.upv.es:10251/2265932026-06-13T07:49:27Z
score 15,81155